To further characterize our patient's cohort and identify frequently occurring mutations in ccRCC tumors we performed targeted amplicon sequencing of the entire coding regions and adjacent intronic sequences of the PBRM1, BAP1 and KDM5C genes. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.